Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance

Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance

Bibliographic Details
Main Authors:	Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Brazilian Journal of Anesthesiology
Online Access:	http://www.sciencedirect.com/science/article/pii/S0104001423000775

Similar Items

Is insulin resistance truly responsible for post-COVID depression?
by: Josef Finsterer, et al.
Published: (2023-07-01)

Genetic work-up of hereditary spastic paraplegias is crucial for classifying these disorders
by: Josef Finsterer, et al.

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
by: Josef Finsterer, et al.
Published: (2022-05-01)

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
by: Josef Finsterer, et al.
Published: (2021-10-01)

Early white matter changes on diffusion tensor imaging in amyotrophic lateral sclerosis
by: Josef Finsterer, et al.
Published: (2020-07-01)

Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated; Comment on "COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature"
by: Josef Finsterer, et al.
Published: (2020-11-01)

Metabolic or ischemic stroke in succinic semi-aldehyde dehydrogenase deficiency due to the homozygous variant c. 1343 + 1_1343 + 3delGTAinsTT in ALDH5A1
by: Josef Finsterer, et al.
Published: (2021-01-01)

COVID-19 associated cranial nerve neuropathy: A systematic review
by: Josef Finsterer, et al.
Published: (2022-02-01)

Presentation and pathophysiology of neuro-COVID
by: Josef Finsterer, et al.
Published: (2021-08-01)

The pathogenicity of variant c.597dup in <i>SLC19A3</i> and treatability of its phenotype remain unconfirmed
by: Josef Finsterer, et al.
Published: (2024-04-01)

Various neurological and non‐neurologic pathophysiological mechanisms can explain SARS‐CoV‐2‐related bilateral vocal cord paralysis
by: Josef Finsterer, et al.
Published: (2023-12-01)

Progressive multifocal leukoencephalopathy cannot be due to liver cirrhosis alone
by: Fulvio A. Scorza, et al.
Published: (2024-02-01)

The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria
by: Josef Finsterer, et al.
Published: (2023-12-01)

Before blaming SARS-CoV-2 for venous sinus thrombosis in a septic patient, consider alternative etiologies
by: Josef Finsterer, et al.
Published: (2023-03-01)

Guillain–Barre syndrome with pleocytosis requires workup for cerebral disease
by: Josef Finsterer, et al.
Published: (2023-05-01)

Comparing Neuro-COVID-19 between waves requires clear cohort selection
by: Josef Finsterer, et al.
Published: (2023-01-01)

Fatal, hemorrhagic stroke despite thrombectomy after Tirone-David procedure in novel compound heterozygous Marfan syndrome
by: Josef Finsterer, et al.
Published: (2022-09-01)

Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
by: Josef Finsterer, et al.
Published: (2022-09-01)

Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’
by: Josef Finsterer, et al.
Published: (2022-06-01)

Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1
by: Josef Finsterer, et al.
Published: (2021-01-01)

Perspectives of Neuro-COVID: Myasthenia
by: Josef Finsterer, et al.
Published: (2021-02-01)

Guillain-Barre syndrome in 220 patients with COVID-19
by: Josef Finsterer, et al.
Published: (2021-05-01)

Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
by: Josef Finsterer, et al.
Published: (2021-12-01)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
by: Josef Finsterer, et al.
Published: (2020-12-01)

Extrapulmonary onset manifestations of COVID-19
by: Josef Finsterer, et al.
Published: (2021-07-01)

Diagnosing SARS-CoV-2 vaccination associated rhombencephalitis requires comprehensive work-up and exclusion of differentials
by: Josef Finsterer, et al.
Published: (2022-03-01)

Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
by: Josef Finsterer, et al.
Published: (2021-03-01)

Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
by: Josef Finsterer, et al.
Published: (2021-02-01)

El inicio de Takotsubo siete días después de la crisis miasténica sugiere un desencadenante alternativo
by: Josef Finsterer, et al.
Published: (2022-01-01)

Exploring the Prospective Role of Propolis in Modifying Aging Hallmarks
by: Carla Scorza, et al.
Published: (2024-02-01)

Is unilateral facial palsy truly caused by SARS-CoV-2?
by: Josef Finsterer, et al.
Published: (2021-03-01)

Myotonic Dystrophy-1 and Parkinson's disease: Clarify the role of CTG-repeat size and variants in VPS13C, SYNJ1, and DNAJC6
by: Josef Finsterer, et al.
Published: (2023-01-01)

Abnormal cerebrospinal fluid composition can accompany central nervous system involvement in COVID-19
by: Josef Finsterer, et al.
Published: (2022-09-01)

Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit
by: Josef FINSTERER, et al.
Published: (2021-07-01)

Weak evidence for a relation between bipolar disorder and heterozygous ZNF92 and CLN6 variants
by: Josef Finsterer, et al.
Published: (2023-02-01)

Ischemic stroke in 455 COVID-19 patients
by: Josef Finsterer, et al.
Published: (2022-04-01)

Parkinson-related neuropathy
by: Josef Finsterer, et al.
Published: (2021-02-01)

Multifocal T2-/DWI-hyperintense cerebral lesions in COVID-19 not necessarily imply demyelination
by: Josef FINSTERER, et al.
Published: (2021-02-01)

Workup for cerebral involvement in COVID-19 requires cerebral imaging, electroencephalography, and cerebrospinal fluid studies
by: Carla A. Scorza, et al.
Published: (2022-12-01)

SARS-CoV-2 infection- or vaccination-related neurological disease requires careful investigation
by: Daniel Matovu, et al.
Published: (2022-01-01)